LUPUS NEXUS LANDMARK STUDY: A PROSPECTIVE REGISTRY AND BIOREPOSITORY
The Lupus Research Alliance is launching the Lupus Landmark Study, a groundbreaking health research study that will improve personalized treatments for people living with lupus. This will be the largest study of its kind in lupus research, and will include 3,500 adults diagnosed with lupus.
The study aims to transform lupus research and drug development through the creation of a research platform. The platform will be a source of important clinical data, patient reported data, and biological samples that will catalyze global collaboration, innovation, and precision medicine approaches in lupus.
null
Participation Requirements
-
Sex:
Male, Female, Intersex -
Eligible Ages:
18 and up
Participation Criteria
Inclusion Criteria:
Participants must be:
Able to understand and comply with study procedures and voluntarily sign a written informed consent document
Age18 years or older at the time of enrolment
Have a diagnosis of Systemic Lupus Erythematosis
Exclusion Criteria:
Those who are currently pregnant.
Those whose age is less than 18 years.
Study Location
University of Calgary
University of CalgaryCalgary, Alberta
Canada
Contact Study Team
- Study Sponsored By
- University of Calgary
- Participants Required
- More Information
- Study ID:
REB23-1555